Enveric Biosciences Financials - Benzinga

Enveric Biosciences Inc

ENVBNASDAQ

Trade with Public

Trade with Public

$1.39

-0.05-3.47%

At close: Sep 4, 5:00 PM EST

$1.44

0.04993.59%

After Hours: Sep 4, 9:12 AM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

Enveric Biosciences Financials

Enveric Biosciences (ENVB) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Enveric Biosciences Q2 EPS $(0.76) Up From $(11.64) YoY

Enveric Biosciences (NASDAQ:ENVB) reported quarterly losses of $(0.76) per share. This is a 93.47 percent increase over losses of $(11.64) per share from the same period last year.

Benzinga Newsdesk

PRO
Enveric Biosciences Q1 EPS $(1.08) Up From $(14.64) YoY

Enveric Biosciences (NASDAQ:ENVB) reported quarterly losses of $(1.08) per share. This is a 92.62 percent increase over losses of $(14.64) per share from the same period last year.

Benzinga Newsdesk

PRO
Enveric Biosciences Q4 EPS $(0.50) Up From $(57.96) YoY

Enveric Biosciences (NASDAQ:ENVB) reported quarterly losses of $(0.50) per share. This is a 99.14 percent increase over losses of $(57.96) per share from the same period last year.

Benzinga Newsdesk

Crude Oil Moves Lower; Photronics Shares Surge After Q4 Results

Avi Kapoor

US Stocks Mixed Ahead Of Fed Decision; Dow Surges 100 Points

Avi Kapoor

PRO
Enveric Biosciences Q3 EPS $(10.81) Up From $(43.10) YoY

Benzinga Newsdesk